The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10–driven MARCH1-mediated ubiquitination and degradation
Open accessAbstract
Effective vaccine adjuvants must induce expression of major histocompatability (MHC) class II proteins and the costimulatory molecule CD86 on dendritic cells (DCs). However, some adjuvants elicit production of cytokines resulting in adverse inflammatory consequences. Development of agents that selectively increase MHC class II and CD86 expression without triggering unwanted cytokine production requires a better understanding of the molecular mechanisms influencing the production and degradation of MHC class II and CD86 in DCs. Here, we investigate how CD83, an immunoglobulin protein expressed on the surface of mature DCs, promotes MHC class II and CD86 expression. Using mice with an N-ethyl-N-nitrosourea–induced mutation eliminating the transmembrane (TM) region of CD83, we found that the TM domain of CD83 enhances MHC class II and CD86 expression by blocking MHC class II association with the ubiquitin ligase MARCH1. The TM region of CD83 blocks interleukin 10–driven, MARCH1-dependent ubiquitination and degradation of MHC class II and CD86 in DCs. Exploiting this posttranslational pathway for boosting MHC class II and CD86 expression on DCs may provide an opportunity to enhance the immunogenicity of vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vinuesa, C. G., Cook, M. C., Angelucci, C., Athanasopoulos, V., Rui, L., Hill, K. M., Yu, D., Domaschenz, H., Whittle, B., Lambe, T., et al. (2005) · Nature · doi:10.1038/nature03555 · Cited by 862 · cited 1×
“ENU mutagenesis of male C57BL/6 and breeding was done as previously described (Vinuesa et al., 2005).”
MethodSelf-citation
Cited by
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Neefjes, J., Jongsma, M. L. M., Paul, P., & Bakke, O. (2011) · Nature Reviews Immunology · doi:10.1038/nri3084 · Cited by 2,044
The ins and outs of MHC class II-mediated antigen processing and presentation
Roche, P. A., & Furuta, K. (2015) · Nature reviews. Immunology · doi:10.1038/nri3818 · Cited by 1,207
tTregs, pTregs, and iTregs: similarities and differences
Shevach, E. M., & Thornton, A. M. (2014) · Immunological Reviews · doi:10.1111/imr.12160 · Cited by 606
Ubiquitin signaling in immune responses
Hu, H., & Sun, S.-C. (2016) · Cell Research · doi:10.1038/cr.2016.40 · Cited by 485
Dalod, M., Chelbi, R., Malissen, B., & Lawrence, T. (2014) · The EMBO Journal · doi:10.1002/embj.201488027 · Cited by 437
The role of ubiquitylation in immune defence and pathogen evasion
Jiang, X., & Chen, Z. J. (2012) · Nature Reviews Immunology · doi:10.1038/nri3111 · Cited by 353
Suppression of antigen presentation by IL-10
Mittal, S. K., & Roche, P. A. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.12.009 · Cited by 314
Dendritic cells as shepherds of T cell immunity in cancer
Pittet, M. J., Di Pilato, M., Garris, C., & Mempel, T. R. (2023) · Immunity · doi:10.1016/j.immuni.2023.08.014 · Cited by 313
Hong, S., Zhang, Z., Liu, H., Tian, M., Zhu, X., Zhang, Z., Wang, W., Zhou, X., Zhang, F., Ge, Q., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.012 · Cited by 296
Antigen processing and presentation
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.07.005 · Cited by 194
The CD83 molecule - an important immune checkpoint
Grosche, L., Knippertz, I., König, C., Royzman, D., Wild, A. B., Zinser, E., Sticht, H., Muller, Y. A., Steinkasserer, A., & Lechmann, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00721 · Cited by 138
“results in a lack of MHCII surface expression (48).”
BackgroundInfluentialThe Membrane-Associated MARCH E3 Ligase Family: Emerging Roles in Immune Regulation
Lin, H., Li, S., & Shu, H.-B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01751 · Cited by 124
Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells
Baravalle, G., Park, H., McSweeney, M., Ohmura-Hoshino, M., Matsuki, Y., Ishido, S., & Shin, J.-S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101643 · Cited by 115
Self-citationThe monocytic cell line THP-1 as a validated and robust surrogate model for human dendritic cells
Hölken, J. M., & Teusch, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021452 · Cited by 47
Pinho, M. P., Migliori, I. K., Flatow, E. A., & Barbuto, J. A. M. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.0413239 · Cited by 39
Dissecting mammalian immunity through mutation
Siggs, O. M. (2014) · Immunology & Cell Biology · doi:10.1038/icb.2014.8 · Cited by 20
Metadata
- Authors
- Tze, L. E., Horikawa, K., Domaschenz, H., Howard, D. R., Roots, C. M., Rigby, R. J., Way, D. A., Ohmura-Hoshino, M., Ishido, S., Andoniou, C. E., Degli-Esposti, M. A., & Goodnow, C. C.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2011-01-10
- Volume
- 208
- Issue
- 1
- Pages
- 149-165
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2160375521
- Cited by
- 232
- References
- 1
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.